Previous 10 | Next 10 |
home / stock / biov:cc / biov:cc news
BioVaxys Further Expands Vaccines Intellectual Property Portfolio Canada NewsWire VANCOUVER, BC , Sept. 28, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that in an action that...
BIOVAXYS CLOSES FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT Canada NewsWire VANCOUVER, BC , Sept. 19, 2022 /CNW/ -- BioVaxys Technology Corp. ( CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ( "BioVaxys" or the "Company") is pleased to announce that it has cl...
BioVaxys Announces New Chief Financial Officer Canada NewsWire VANCOUVER, BC , Sept. 8, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that Mr. Craig Loverock ha...
BioVaxys announces completed synthesis of its Pan-Sarbecovirus Vaccine candidate and launch of in vivo animal study Canada NewsWire VANCOUVER, BC , Sept. 6, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys...
BIOVAXYS ANNOUNCES WARRANT EXTENSION Canada NewsWire VANCOUVER, BC , Aug. 9, 2022 /CNW/ -- BioVaxys Technology Corp. ( CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ( " BioVaxys " or the " Company ") announces that it has extended the expiry dat...
BIOVAXYS ANNOUNCES NON-BROKERED PRIVATE PLACEMENT Canada NewsWire VANCOUVER, British Columbia , Aug. 4, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys" or the "Company") is pleased to announce a non-brokered ...
BIOVAXYS ANNOUNCES COMPLETED DEBT SETTLEMENT Canada NewsWire VANCOUVER, B.C. , Aug. 2, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") further to its news release dated July 4, 2022 , Bi...
BIOVAXYS ANNOUNCES PROPOSED DEBT SETTLEMENT Canada NewsWire VANCOUVER, B.C. , July 4, 2022 /CNW/ - BioVaxys Technology Corp. ( CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that is proposing to settle an aggregat...
Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development Canada NewsWire VANCOUVER, BC , June 15, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVA...
Bio-Manufacturing Partner BioElpida Completes Next Phase of BVX-0918 GMP Production for EU Clinical Study Canada NewsWire VANCOUVER, BC , June 8, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), anno...
News, Short Squeeze, Breakout and More Instantly...
Biovaxys Technology Corp. Company Name:
BIOV:CC Stock Symbol:
CNQC Market:
Biovaxys Technology Corp. Website:
Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor Canada NewsWire VANCOUVER, BC , July 18, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Brittany Davison , ...
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF TRIAL TO TEST IMMUNOCONTRACEPTION IN ASIAN ELEPHANTS Canada NewsWire VANCOUVER, BC and MADISON, Wis. , July 17, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys...
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order PR Newswire VANCOUVER, BC , May 16, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") announces that the Ontario Securities Commission (...